Literature DB >> 25673026

Immunotherapy in all aspects.

Deniz Hanci1, Ethem Şahin2, Nuray Bayar Muluk3,4, Cemal Cingi5.   

Abstract

Allergen immunotherapy is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy. In this review, we presented the important topics in immunotherapy. The important aspects of immunotherapy are considered to be "Immunologıcal responses to immunotherapy"; "The principal types of immunotherapy"; "Effectiveness"; "Indications"; "Contraindications"; "Allergen immunotherapy in children"; "Safety"; and "Anaphylactic reactions after immunotherapy". The principal types of immunotherapy are subcutaneous immunotherapy (SCIT) and sublingual immunotherapy. Both of them can be used in indicated cases. When using SCIT, physicians must be more careful because of reported rare fatal cases. The risks and benefits of continuing allergen immunotherapy in patients who have experienced severe systemic reactions should be carefully considered.

Entities:  

Keywords:  Effectiveness; Immunotherapy; Safety; Subcutaneous immunotherapy (SCIT); Sublingual immunotherapy (SLIT)

Mesh:

Year:  2015        PMID: 25673026     DOI: 10.1007/s00405-015-3553-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  107 in total

1.  Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity.

Authors:  M J Furin; P S Norman; P S Creticos; D Proud; A Kagey-Sobotka; L M Lichtenstein; R M Naclerio
Journal:  J Allergy Clin Immunol       Date:  1991-07       Impact factor: 10.793

2.  Anaphylaxis to sublingual immunotherapy.

Authors:  E H Dunsky; M F Goldstein; D J Dvorin; G A Belecanech
Journal:  Allergy       Date:  2006-10       Impact factor: 13.146

3.  Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy').

Authors:  E Alvarez-Cuesta; J Bousquet; W G Canonica; S Durham; H-J Malling; G Passalacqua; E Valovirta
Journal:  Allergy       Date:  2008-07       Impact factor: 13.146

4.  Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

Authors:  Martin Penagos; Enrico Compalati; Francesco Tarantini; Rodrigo Baena-Cagnani; Jose Huerta; Giovanni Passalacqua; Giorgio Walter Canonica
Journal:  Ann Allergy Asthma Immunol       Date:  2006-08       Impact factor: 6.347

Review 5.  Systemic reactions and fatalities associated with allergen immunotherapy.

Authors:  R F Lockey; G L Nicoara-Kasti; D S Theodoropoulos; S C Bukantz
Journal:  Ann Allergy Asthma Immunol       Date:  2001-07       Impact factor: 6.347

6.  Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

Authors:  V A Varney; Q A Hamid; M Gaga; S Ying; M Jacobson; A J Frew; A B Kay; S R Durham
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.

Authors:  Piero Maestrelli; Luisa Zanolla; Marcella Pozzan; Leonardo M Fabbri
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

8.  Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

Authors:  David I Bernstein; Mark Wanner; Larry Borish; Gary M Liss
Journal:  J Allergy Clin Immunol       Date:  2004-06       Impact factor: 10.793

Review 9.  Mechanisms of sublingual immunotherapy.

Authors:  Guy Scadding; Stephen Durham
Journal:  J Asthma       Date:  2009-05       Impact factor: 2.515

10.  Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.

Authors:  Anthony J Frew; Richard J Powell; Christopher J Corrigan; Stephen R Durham
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

View more
  2 in total

Review 1.  Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children.

Authors:  Sophia Tsabouri; Antigoni Mavroudi; Gavriela Feketea; George V Guibas
Journal:  Front Pediatr       Date:  2017-04-21       Impact factor: 3.418

2.  Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Authors:  Mustafa Cenk Ecevit; Müge Özcan; İlknur Haberal Can; Emel Çadallı Tatar; Serdar Özer; Erkan Esen; Doğan Atan; Sercan Göde; Çağdaş Elsürer; Aylin Eryılmaz; Berna Uslu Coşkun; Zahide Mine Yazıcı; Mehmet Emre Dinç; Fatih Özdoğan; Kıvanç Günhan; Nagihan Bilal; Arzu Yasemin Korkut; Fikret Kasapoğlu; Bilge Türk; Ela Araz Server; Özlem Önerci Çelebi; Tuğçe Şimşek; Rauf Oğuzhan Kum; Mustafa Kemal Adalı; Erdem Eren; Nesibe Gül Yüksel Aslıer; Tuba Bayındır; Aslı Çakır Çetin; Ayşe Enise Göker; Işıl Adadan Güvenç; Sabri Köseoğlu; Gül Soylu Özler; Ethem Şahin; Aslı Şahin Yılmaz; Ceren Güne; Gökçe Aksoy Yıldırım; Bülent Öca; Mehmet Durmuşoğlu; Yunus Kantekin; Süay Özmen; Gözde Orhan Kubat; Serap Köybaşı Şanal; Emine Elif Altuntaş; Adin Selçuk; Haşmet Yazıcı; Deniz Baklacı; Atılay Yaylacı; Deniz Hancı; Sedat Doğan; Vural Fidan; Kemal Uygur; Nesil Keleş; Cemal Cingi; Bülent Topuz; Salih Çanakçıoğlu; Metin Önerci
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.